Clinical Trial Update: If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ivabradine for diastolic heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: St Vincent's University Hospital, Ireland | Conditions: Diastolic Heart Failure | Phase 2 | Status: WITHDRAWN